PS Pershing Square Inc.

P/E --
Forward P/E 51.55
Price/Sales 28.33
Beta --
Div Yield --
Market Cap --

Company Analysis

Latest News

🔴 Pershing Square is trading 10% down today after BofA cuts rating and target

Pershing Square is trading 10.13% lower at $48.73 after BofA Securities downgraded the stock. - BofA cut its rating to Underperform from Neutral and lowered...

BofA Downgrades Pershing Square to Underperform: Can Ackman's Portfolio Pivot Fast Enough to Close the Gap?

BofA Downgrades Pershing Square to Underperform: Can Ackman's Portfolio Pivot Fast Enough to Close the Gap?

Shares of Pershing Square Inc. tumbled 7.5% to $50.15 on Tuesday after BofA Securities cut the stock to Underperform — a rare outright sell-equivalent call —...

🔴 Pershing Square is trading 7.5% down today after BofA Securities cuts rating to Underperform

Pershing Square is trading at $50.15, down 7.5%, after BofA Securities downgraded it to Underperform from Neutral and cut its price target. - BofA lowered its...

🔴 Pershing Square is trading 4.1% down today after Citi's Sell downgrade over valuation concerns

Pershing Square is trading 4.06% down at $52.13 after Citi Research downgraded the shares to Sell/High Risk from Neutral/High Risk, citing valuation...

🟢 Pershing Square is trading 4.8% up in after-hours trading

Pershing Square is trading at $57.00, up 4.83% in after-hours trading; no clear company-specific catalyst was identified. - The gain reverses a 7.29%...

🔴 Pershing Square is trading 4.6% down today amid rising oil and Treasury yields

Pershing Square is trading at $55.96, down 4.59%, with macro pressure the clearest available context, not a confirmed sole cause. - No fresh company-specific...

🔴 Pershing Square is trading 5.6% down today as Treasury yields and oil prices weigh

Pershing Square is trading at $56.41, down 5.64%, amid broader market pressure ahead of Federal Reserve minutes; available reporting identified no fresh...

🟢 Pershing Square is trading 5% up today with no fresh company-specific catalyst identified

Pershing Square is trading at $57.69, up 5.14% on October 6, 2026; no fresh company-specific catalyst has been identified, while broader-market gains may...

🟢 Pershing Square is trading 5.9% up in pre-market with no identified company-specific catalyst

Pershing Square is trading 5.87% higher in pre-market at $58.09 on October 6, with no fresh company-specific announcement clearly explaining the move. - Its...

🔴 Pershing Square is trading 4.13% down with no clear company-specific catalyst identified

Pershing Square is trading 4.13% down at $53.63 on October 1, 2026; no clear company-specific catalyst was identified. - Broader markets are under pressure as...

🟢 Pershing Square is trading 5.7% up in pre-market with no identified catalyst

Pershing Square is trading at $59.13, up 5.70%, with no clear company-specific announcement identified to explain the pre-market rise. - A pre-market scan...

🟢 Pershing Square is trading 4% up with no clear catalyst identified

Pershing Square is trading 4.00% up at $55.70 on September 30, 2026, with no new company-specific announcement identified to explain the rise. - Jones Trading...

🔴 Pershing Square is trading 4.22% down amid overbought technical indicators

Pershing Square is trading at $56.67, down 4.22%, with no clear company-specific announcement identified to explain the September 29 decline. - Available...

🟢 Pershing Square is trading 4.4% up

Pershing Square is trading at $58.64, up 4.42%; no new company-specific announcement explaining the September 28 move was identified. - Investor’s Business...

🟢 Pershing Square is trading at 4.7% up today after co-leading Precision Neuroscience's $250 million financing

Pershing Square is trading 4.7% higher at $54.75 after co-leading Precision Neuroscience’s oversubscribed $250 million Series D financing. - The round values...

Pershing Square co-leads $250M for Precision Neuroscience, targeting brain injury recovery

Pershing Square co-led an oversubscribed $250 million Series D financing round for Precision Neuroscience. The Ackman Oxman Institute and other life sciences...

🟢 Pershing Square is trading 4.54% up today with no clear company-specific catalyst

Pershing Square is trading 4.54% higher at $52.26, with no fresh company-specific catalyst identified. - The move reverses the 2.71% decline on September 23...

🔴 Pershing Square is trading at 4.8% down today amid broader financial-sector and macro pressure

Pershing Square is trading at $48.90, down 4.8%, mainly amid broader financial-sector and macro pressure. - The decline reverses part of the sharp gains...

🟢 Pershing Square is trading 5.6% up today amid valuation momentum

Pershing Square is trading at $50.91, up +5.56%, amid valuation momentum after recovering from the prior session’s decline. - On September 22, 2026, no new...

🔴 Pershing Square is trading 6.3% down today after recent sharp advance

Pershing Square is trading 6.3% down at $46.70, reversing part of its sharp recent advance after closing at $49.83 on September 18. - No new company-specific...